Torrent Pharmaceuticals Limited has informed the Exchange about Investor Presentation

TORNTPHARM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

-1.1%1-day move

₹4497.00

prior close

₹4525.00

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

+1.6+2.2+2.7+3.2-1.1+0.7-1.8-3.3-4.8-3.7-0.6+0.5+11.4—

Up moveDown movePending

AI summary

Torrent Pharmaceuticals submitted its Q4 and full-year FY26 analyst presentation. Q4 FY26 revenue grew 43% year-on-year to Rs 2,215 crore, driven primarily by Brazil which surged 68% to Rs 798 crore. Full-year FY26 revenue reached Rs 13,980 crore, up 21% from Rs 11,516 crore in FY25. India contributed Rs 1,363 crore (24% growth) and Germany Rs 1,249 crore (24% growth) for the year. All regions showed robust double-digit growth, with Brazil being the fastest-growing market in Q4.

Likely market impact

Strong top-line growth across all markets is positive for the stock, though the filing contains only revenue data without margin or profit information, so the full earnings picture remains incomplete.